Literature DB >> 20178553

Paraaortic paraganglioma arising in an ovarian carcinoma patient mimicking lymph node metastasis.

Fumihisa Chishima1, Masaaki Tamura, Teine Nakazawa, Masahiko Sugitani, Daisaku Hirano, Tetsuo Yoshikawa, Fumi Fuchinoue, Norimichi Nemoto, Tatsuo Yamamoto.   

Abstract

Paragangliomas are rare tumors arising from the chromaffin cells in the autonomic nervous system. While they both occur most frequently along the paraaortic chain, paraganglioma and ovarian carcinoma very rarely occur together. A 61-year-old, post-menopausal woman visited our hospital, with complaints of abdominal pain and genital bleeding. Image analysis showed a 21 x 18 x 10 cm ovarian mass, and a 38 mm tumor at the paraaortic lesion. First, she underwent bilateral salpingo-oophorectomy. Serous papillary cystadenocarcinoma of the left ovary was found, and so a second surgery was performed. The paraaortic tumor was completely eliminated in spite of fluctuating blood pressure intraoperatively. Microscopic examination revealed that the paraaortic tumor was paraganglioma. She was ultimately diagnosed as having ovarian carcinoma stage Ia (FIGO) with coincident paraganglioma. If blood pressure fluctuation is observed during dissection of the paraaortic lymph node, paraganglioma should be suspected and blood pressure must be carefully controlled.

Entities:  

Mesh:

Year:  2010        PMID: 20178553     DOI: 10.1111/j.1447-0756.2009.01094.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  2 in total

1.  Paraganglioma of the vagina: a case report and review of the literature.

Authors:  Tao Cai; Yucong Li; Qingming Jiang; Dong Wang; Yu Huang
Journal:  Onco Targets Ther       Date:  2014-06-10       Impact factor: 4.147

2.  Simultaneous resection of endometrial cancer and high-level paraaortic paraganglioma using retroperitoneoscopic surgery.

Authors:  Kohshiro Nakao; Harumichi Banno; Tsuyoshi Kondo; Shinya Hirabuki; Hiromasa Sasaki; Tsutomu Hoshiba
Journal:  Gynecol Oncol Rep       Date:  2018-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.